share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股sec公告 ·  05/20 16:51
Moomoo AI 已提取核心訊息
On May 14, 2024, Applied UV, Inc., a company listed on The Nasdaq Stock Market LLC under the trading symbols AUVI for its common stock and AUVIP for its 10.5% Series A Cumulative Perpetual Preferred Stock, reported a significant change in its financial oversight. The company announced that Mazars USA LLP, its independent registered public accounting firm, officially resigned. This resignation was anticipated following an advisory notice from Mazars on April 17, 2024, stating their intention to resign effective with the filing of Applied UV's Quarterly Report for the period ended March 31, 2024, and no later than May 31, 2024. The audit reports for the fiscal years ended December 31, 2023, and December 31, 2022, by Mazars did not contain any adverse opinion or disclaimer and were not qualified or modified...Show More
On May 14, 2024, Applied UV, Inc., a company listed on The Nasdaq Stock Market LLC under the trading symbols AUVI for its common stock and AUVIP for its 10.5% Series A Cumulative Perpetual Preferred Stock, reported a significant change in its financial oversight. The company announced that Mazars USA LLP, its independent registered public accounting firm, officially resigned. This resignation was anticipated following an advisory notice from Mazars on April 17, 2024, stating their intention to resign effective with the filing of Applied UV's Quarterly Report for the period ended March 31, 2024, and no later than May 31, 2024. The audit reports for the fiscal years ended December 31, 2023, and December 31, 2022, by Mazars did not contain any adverse opinion or disclaimer and were not qualified or modified, except for an explanatory paragraph regarding the company's ability to continue as a going concern. There were no disagreements on accounting principles or practices, financial statement disclosure, or auditing scope or procedure between the company and Mazars during the fiscal years mentioned and up to the resignation date. Furthermore, there were no reportable events as defined in Item 304(a)(1)(v) of Regulation S-K. Applied UV has received a letter from Mazars, dated May 20, 2024, agreeing with the statements made in the disclosure, which is attached as Exhibit 16.1 to the report filed with the SEC. The report was signed by Mike Riccio, Chief Financial Officer of Applied UV, Inc.
2024年5月14日,在納斯達克股票市場有限責任公司上市的公司,其普通股的交易代碼爲AUVI,其10.5%的A系列累積永久優先股的交易代碼爲AUVIP,其財務監督發生了重大變化。該公司宣佈,其獨立註冊會計師事務所Mazars USA LLP正式辭職。此次辭職是在瑪扎爾於2024年4月17日發出諮詢通知後預料的,該通知表示他們打算辭職,自應用紫外光提交截至2024年3月31日的季度報告起生效,不遲於2024年5月31日。瑪澤截至2023年12月31日和2022年12月31日的財政年度的審計報告不包含任何負面意見或免責聲明,除了一段關於公司繼續經營能力的解釋性段落外,沒有保留意見或修改。在上述財政...展開全部
2024年5月14日,在納斯達克股票市場有限責任公司上市的公司,其普通股的交易代碼爲AUVI,其10.5%的A系列累積永久優先股的交易代碼爲AUVIP,其財務監督發生了重大變化。該公司宣佈,其獨立註冊會計師事務所Mazars USA LLP正式辭職。此次辭職是在瑪扎爾於2024年4月17日發出諮詢通知後預料的,該通知表示他們打算辭職,自應用紫外光提交截至2024年3月31日的季度報告起生效,不遲於2024年5月31日。瑪澤截至2023年12月31日和2022年12月31日的財政年度的審計報告不包含任何負面意見或免責聲明,除了一段關於公司繼續經營能力的解釋性段落外,沒有保留意見或修改。在上述財政年度以及截至辭職之日,公司與瑪澤之間在會計原則或慣例、財務報表披露或審計範圍或程序方面沒有分歧。此外,沒有發生S-K法規第304(a)(1)(v)項中定義的應報告事件。應用紫外線已收到瑪澤於2024年5月20日發出的信函,信中同意披露中的聲明,該披露作爲附錄16.1附於向美國證券交易委員會提交的報告中。該報告由應用紫外光公司首席財務官邁克·裏喬簽署。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息